Influence of MRI contrast media on histamine release from mast cells

Polish Journal of Radiology

Volumn 77, Issue 3, 2012, Pages 19-24

  Kun, Tomasz ^a   Jakubowski, Lucjusz ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Anaphylactic reaction; Histamine; Mast cell; MRI contrast media

Indexed keywords

GADOLINIUM; MACROGOL; PENTETIC ACID;

ANAPHYLAXIS; ANIMAL CELL; ARTICLE; CELL ISOLATION; CELL STIMULATION; EXPERIMENTAL MODEL; HISTAMINE RELEASE; IN VITRO STUDY; MALE; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSMOSIS; PERITONEAL FLUID; RAT;

EID: 84866184343     PISSN: 1733134X     EISSN: 18990967     Source Type: Journal    
DOI: 10.12659/pjr.883370     Document Type: Article

References (34)

1. Brzezinska-Blaszczyk E, Zalewska A: Sensitivity of human cutaneous mast cells to anaphylactic and nonimmunological stimuli. Arch Immunol Ther Exp, 1997; 45: 55-59
2. Metcalfe DD, Baram D, Mekori YA: Mast cells. Physiol Rev, 1997; 77: 1033-79
3. Brzezinska-Blaszczyk E, Forczmanski M, Pietrzak A: The action of tumor necrosis factor-alpha on rat mast cells. J Interferon Cytokine Res, 2000; 20: 377-82
4. Szebeni J: Hypersensitivity reactions to radiocontrast media: the role of complement activation. Curr Allergy Asthma Rep, 2004; 4: 25-30
5. Morcos SK, Thomsen HS, Exley CM: Contrast media: interactions with other drugs and clinical tests. Eur Radiol, 2005; 15: 1463-68
6. Deftereos S, Giannopoulos G, Kossyvakis C et al: Effect of radiographic contrast media on markers of complement activation and apoptosis in patients with chronic coronary artery disease undergoing coronary angiography. J Invasive Cardiol, 2009; 21: 473-77
7. Murphy KJ, Brunberg JA, Cohan RH: Adverse reactions to gadolinium contrast media: a review of 36 cases. AJR Am J Roentgenol, 1996; 167: 847-49
8. Runge VM: Safety of approved MR contrast media for intravenous injection. J Magn Reson Imaging, 2000; 12: 205-13
9. Jordan RM, Mintz RD: Fatal reaction to gadopentetate dimeglumine. AJR Am J Roentgenol, 1995; 164: 743-44
10. Li A, Wong CS, Wong MK et al: Acute adverse reactions to magnetic resonance contrast media - gadolinium chelates. Br J Radiol, 2006; 79: 368-71
11. Kalogeromitros DC, Makris MP, Aggelides XS et al: Anaphylaxis to gadobenate dimeglumine (Multihance): a case report. Int Arch Allergy Immunol, 2007; 144: 150-54
12. Singer BD, Woodrick RS, Pedicano JB: Severe adverse drug reaction to gadobenate dimeglumine. Scientific World Journal, 2009; 9: 363-65
13. Prince MR, Zhang H, Zou Z et al: Incidence of immediate gadolinium contrast media reactions. AJR Am J Roentgenol, 2011; 196: W138-43
14. Mita H, Tadokoro K, Akiyama K: Detection of IgE antibody to a radiocontrast medium. Allergy, 1998; 53: 1133-40
15. Laroche D, Namour F, Lefrancois C et al: Anaphylactoid and anaphylactic reactions to iodinated contrast material. Allergy, 1999; 54(Suppl.58): 13-16
16. Canter LM: Anaphylactoid reactions to radiocontrast media. Allergy Asthma Proc, 2005; 26: 199-203
17. Szebeni J: Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. Toxicology, 2005; 216: 106-21
18. Freyria AM, Lasser EC: Primers of contact system activity in asthmatic patients and contrast material reactors. Invest Radiol, 1988; 23(Suppl.1): S197-99
19. Lasser EC, Lamkin GE, Lyon S: A role for nitric oxide in X-ray contrast material toxicity. Acad Radiol, 1995; 2: 559-64
20. Meth MJ, Maibach HI: Current understanding of contrast media reactions and implications for clinical management. Drug Saf, 2006; 29: 133-41
21. Niendorf HP, Dinger JC, Haustein J et al: Tolerance data of Gd-DTPA: a review. Eur J Radiol, 1991; 13: 15-20
22. Nelson KL, Gifford LM, Lauber-Huber C et al: Clinical safety of gadopentetate dimeglumine. Radiology, 1995; 196: 439-43
23. Findlay SR, Dvorak AM, Kagey-Sobotka A et al: Hyperosmolar triggering of histamine release from human basophils. J Clin Invest, 1981; 67: 1604-13
24. Eggleston PA, Kagey-Sobotka A, Lichtenstein LM: A comparison of the osmotic activation of basophils and human lung mast cells. Am Rev Respir Dis, 1987; 135: 1043-48
25. Runge VM, Dickey KM, Williams NM et al: Local tissue toxicity in response to extravascular extravasation of magnetic resonance contrast media. Invest Radiol, 2002; 37: 393-98
26. Wolf GL, Mishkin MM, Roux SG et al: Comparison of the rates of adverse drug reactions. Ionic contrast agents, ionic agents combined with steroids, and nonionic agents. Invest Radiol, 1991; 26: 404-10
27. Cochran ST: Anaphylactoid reactions to radiocontrast media. Curr Allergy Asthma Rep, 2005; 5: 28-31
28. Bush WH, Swanson DP: Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment. AJR Am J Roentgenol, 1991; 157: 1153-61
29. Peachell PT, Morcos SK: Effect of radiographic contrast media on histamine release from human mast cells and basophils. Br J Radiol, 1998; 71: 24-30
30. Rodriguez RM, Gueant JL, Gastin IA et al: Comparison of effects of ioxaglate versus iomeprol on histamine and tryptase release in patients with ischemic cardiomyopathy. Am J Cardiol, 2001; 88: 185-88
31. Simon MR, Reher RL, Long PM et al: The nonionic radiocontrast medium iopromide does not release endothelin-1 or activate cardiac mast cells during coronary angiography. Int Arch Allergy Immunol, 2003; 131: 53-56
32. Wedeking P, Kumar K, Tweedle MF: Dissociation of gadolinium chelates in mice: relationship to chemical characteristics. Magn Reson Imaging, 1992; 10: 641-48
33. Corot C, Idee JM, Hentsch AM et al: Structure-activity relationship of macrocyclic and linear gadolinium chelates: investigation of transmetallation effect on the zinc-dependent metallopeptidase angiotensin-converting enzyme. J Magn Reson Imaging, 1998; 8: 695-702
34. Morcos SK: Extracellular gadolinium contrast agents: differences in stability. Eur J Radiol, 2008; 66: 175-79.